Request Demo
Last update 27 Feb 2026
Recombinant adenovirus-hepatocyte growth factor(Academy of Military Medical Sciences)
Last update 27 Feb 2026
Overview
Basic Info
Drug Type Growth factors |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with Recombinant adenovirus-hepatocyte growth factor(Academy of Military Medical Sciences)CTR20130384
冠状动脉旁路移植术同期心肌内注射重组腺病毒-肝细胞生长因子注射液（Ad-HGF）治疗缺血性心脏病IIa期临床研究
[Translation] Phase IIa clinical study of intramyocardial injection of recombinant adenovirus-hepatocyte growth factor injection (Ad-HGF) during coronary artery bypass grafting for the treatment of ischemic heart disease
NCT01925352
Phase 2 Study of Adenovirus Hepatocyte Growth Factor for Treatment of Ischemic Heart Disease
CTR20130385
经心内膜心肌注射重组腺病毒-肝细胞生长因子注射液（Ad-HGF）治疗缺血性心脏病IIa期临床研究
[Translation] Phase IIa clinical study of transendocardial injection of recombinant adenovirus-hepatocyte growth factor injection (Ad-HGF) for the treatment of ischemic heart disease
100 Clinical Results associated with Recombinant adenovirus-hepatocyte growth factor(Academy of Military Medical Sciences)
Login to view more data
100 Translational Medicine associated with Recombinant adenovirus-hepatocyte growth factor(Academy of Military Medical Sciences)
Login to view more data
100 Patents (Medical) associated with Recombinant adenovirus-hepatocyte growth factor(Academy of Military Medical Sciences)
Login to view more data
100 Deals associated with Recombinant adenovirus-hepatocyte growth factor(Academy of Military Medical Sciences)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Angina, Stable | Phase 2 | China | 17 Dec 2014 | |
| Angina, Stable | Phase 2 | China | 17 Dec 2014 | |
| Coronary Artery Disease | Phase 2 | - | 27 Sep 2013 | |
| Coronary Artery Disease | Phase 2 | - | 27 Sep 2013 | |
| Myocardial Infarction | Phase 2 | China | 01 Nov 2010 | |
| Myocardial Infarction | Phase 2 | China | 01 Nov 2010 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free